RT-CGM in Young Adults at Risk of DKA

NARecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 3, 2020

Primary Completion Date

June 30, 2022

Study Completion Date

June 30, 2022

Conditions

Diabetes MellitusDiabetes Mellitus, Type 1Glucose Metabolism DisordersMetabolic DiseaseAutoimmune DiseasesEndocrine System Diseases

Interventions

DEVICE

Dexcom G6

Realtime Continous Glucose Monitoring

DEVICE

Self monitoring of blood glucose

Finger prick self monitoring of blood glucose

Trial Locations (1)

RECRUITING

Imperial College Clinical Research Facility, London

All Listed Sponsors

collaborator

DexCom, Inc.

INDUSTRY

lead

Imperial College London

OTHER

NCT04039763 - RT-CGM in Young Adults at Risk of DKA | Biotech Hunter | Biotech Hunter